Vanessa Raymont
MBChB MSc FRCPsych
Associate Professor, R&D Director Oxford Health NHS Foundation Trust
- Honorary Senior Clinical Research Fellow, University of Edinburgh
- Honorary Consultant Psychiatrist
My clinical and research interests are in traumatic brain injury, and memory disorders and dementia, as well as clinical trials and biomarkers in cognitive impairment, having worked for over 30 years in clinical trials in the UK and US.
I am currently principal investigator for the Brains for Dementia Research (BDR) studies and multiple commercial early and late phase dementia clinical trials. I am Chief Investigator on the Deep and Frequent Phenotyping (DFP) study, a NHIR-funded study assessing the use of sertraline to prevent post-head injury depression (STOP-D) and am co-lead of the AD-SMART platform trial and the REAl world Dementia OUTcomes (READ-OUT) blood biomarker study that is part of the Alzheimer's Research UK Blood Biomarker Challenge. I am also Director of Dementia Platforms UK, co-chair of the UK Brain Health Coalition and serve as a Commissioner for the Commission on Human Medicines.